Clinical trial

Ocular Safety and Usability Study for FYB203 PFS

NCT06708637

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-20

PhasePHASE4

Study timeline

Study start (actual)2024-09-20Date precision: day

Registry last updated2024-11-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Branch Retinal Vein Occlusion with Macular Edemaunresolved

Central Retinal Vein Occlusion with Macular Edemaunresolved

Diabetic Macular Edemaunresolved

Diabetic Retinopathyunresolved

Interventions

FYB203 2 mg (0.05 mL of 40 mg/mL)DRUG

Sponsors & collaborators

Formycon AGlead sponsor

Mapped research locations

Long BeachCalifornia, United States1 EugeneOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06708637 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.